$SPDR S&P 500 ETF Trust(SPY)$ Looking strong here, holding above key short-term moving averages and breaking the trendline. The MAG7 is starting to wake up again. $Invesco QQQ(QQQ)$ is a bit softer versus SPY, but still healthy and above its major averages. One thing to note: $Invesco QQQ(QQQ)$ took out its 6/26 low yesterday, so I'm watching for follow-through.
$Invesco QQQ(QQQ)$ The bear case for $SELLAS Life Sciences Group Inc.(SLS)$ keeps getting more interesting. First, the arguments were: - "GPS doesn't work" - "REGAL will fail before it finishes" - "They'll run out of cash" - "Dilution will destroy shareholders" - "80 events are coming any day now" Now we've reached the point where the new claim is: "They'll just fraud the data." It's a pattern where when old narratives fall apart, new ones get created. Meanwhile, the actual facts remain: - Phase 3 REGAL trial is still ongoing. - The IDMC cleared the trial to continue. - The final event threshold still hasn't been reached. - The FDA approved unlimited dosing. - An Expanded Access Program exists. Y
$SPDR S&P 500 ETF Trust(SPY)$ $Invesco QQQ(QQQ)$ It's been a while since we didn't see a significant gap up at the Monday open, turning into one of the most straightforward trades. Selling premium on Fridays has been close to a 100% win rate.